Anna Jaromczyk Prall, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 18101 Prince Philip Dr, Olney, MD 20832 Phone: 919-323-6465 |
Lauren Sundergill, PMHNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 18101 Prince Philip Dr, Olney, MD 20832 Phone: 301-774-8860 |
Alison Wogatske, FNP-C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 18101 Prince Philip Dr Ste 2002, Olney, MD 20832 Phone: 301-774-8686 Fax: 301-774-8685 |
Ashley Collinson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 18101 Prince Philip Dr, Olney, MD 20832 Phone: 301-774-8882 |
Garth Grey, FNP-C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 18121 Georgia Ave Ste 103, Olney, MD 20832 Phone: 301-933-5050 Fax: 301-949-3262 |
Mrs. Lisa Janine Frank, RN, LCSW-C Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 18101 Prince Philip Dr, Olney, MD 20832 Phone: 301-774-8860 |
Kitty Whitmer Albert, R.N.,M.S.N. ,CSP Registered Nurse - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 3416 Olandwood Ct, Suite 201, Olney, MD 20832 Phone: 301-774-9400 Fax: 301-774-5542 |
Mrs. Shoshana Feldman, FNP-C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 18109 Prince Philip Dr, Olney, MD 20832 Phone: 301-774-8962 |
News Archive
For the more than 36 million people plagued by tinnitus, insomnia can have a negative effect on the condition, worsening the functional and emotional toll of chronic ringing, buzzing, hissing or clicking in the head and ears, according to a new study from Henry Ford Hospital in Detroit.
UC San Diego Health is now offering a new minimally invasive approach to provide relief for patients suffering from chronic low back pain (CLBP).
A University of Houston chemist is exploring the link between copper protein molecules in brain cells and neurodegenerative diseases like Alzheimer's.
Actinium Pharmaceuticals, Inc. a biotechnology company focused on developing innovative, alpha particle radiotherapy targeted cancer treatments addressing major unmet medical needs, today announced that it has successfully treated the first cohort of patients in a Phase I/II study of Actimab-A in Acute Myeloid Leukemia (AML) clinical trial. Patients were treated at Memorial Sloan Kettering Cancer Center in New York City.
› Verified 8 days ago